US sends Brazil malaria drug unproven for COVID-19 treatment
WASHINGTON (AP) — The U.S. has sent to Brazil more than 2 million doses of a malaria drug touted by President Donald Trump as potentially protecting against and treating the coronavirus.
The shipment of the drug, hydroxychloroquine, took place even though scientific evidence has not backed up those uses. No large, rigorous scientific studies have found hydroxychloroquine either safe or effective for preventing or treating COVID-19.
Some smaller studies have indicated worse outcomes from those taking the drug. Brazil is now Latin America’s hardest-hit country and continues to see a surge in virus cases.